Merck & Co., Inc. (MRK) FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
Merck & Co., Inc. (NYSE: MRK) FY 2026 Other Release